The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Drug: ondansetron     Quarter: 2016Q3

Total Records: 1,451     Number of Pages: 73

DRUGNAME PT EventCount
Ondansetron Hydrochloride Tablets Constipation 2
Ondansetron Hydrochloride Tablets Drug ineffective 2
Ondansetron Hydrochloride Tablets Dyspepsia 2
Ondansetron Hydrochloride Tablets Product blister packaging issue 2
ONDANSETRON HYDROCHLORIDE. Asthma 2
ONDANSETRON HYDROCHLORIDE. Atrioventricular block 2
ONDANSETRON HYDROCHLORIDE. Atrioventricular septal defect 2
ONDANSETRON HYDROCHLORIDE. Cardiac disorder 2
ONDANSETRON HYDROCHLORIDE. Cardiac septal defect 2
ONDANSETRON HYDROCHLORIDE. Cleft lip and palate 2
ONDANSETRON HYDROCHLORIDE. Coarctation of the aorta 2
ONDANSETRON HYDROCHLORIDE. Congenital arterial malformation 2
ONDANSETRON HYDROCHLORIDE. Congenital great vessel anomaly 2
ONDANSETRON HYDROCHLORIDE. Congenital hypothyroidism 2
ONDANSETRON HYDROCHLORIDE. Craniofacial deformity 2
ONDANSETRON HYDROCHLORIDE. Craniofacial dysostosis 2
ONDANSETRON HYDROCHLORIDE. Cryptorchism 2
ONDANSETRON HYDROCHLORIDE. Cutaneous symptom 2
ONDANSETRON HYDROCHLORIDE. Cystic fibrosis 2
ONDANSETRON HYDROCHLORIDE. Dermatitis atopic 2

Total Records: 1,451     Number of Pages: 73